Mini review · 13 Apr 2026
Conference abstractPublished 5 Jul 2013
Cross-talk between sympathetic overactivity and insulin resistance
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The two major factors related to obesity and metabolic syndrome, sympathetic overactivity and insulin resistance, are closely interrelated. Obesity is accompanied by an increase in sympathetic activity , particularly in the kidney, which could lead to an increase in renin release and contribute to hypertension. Reactive hyperinsulinemia due to overeating, primary tissue insulin resistance, hyperleptinemia and high free fatty acid levels all may promote enhanced sympathic outflow and metabolic syndrome. Although acute administration of insulin in healthy subjects induces vasodilatation and is mediated by the release of nitric oxide (NO), in insulin resistance the NO release is impaired, vasomotor tone increased due to enhanced calcium flux into the vascular smooth muscle cells increasing the sympathetic nervous system activity. Anyhow the exact mechanisms through which insulin resistance and hyperinsulinemia predispose to sympathtic overactivity are not well established. b-adrenergic stimulation has also been shown to inhibit insulin signalling and decrease insulin induced glucose uptake in brown adipocytes. As skletal muscle quantitatively account for the largest portion of whole body insulin resistance it not a surprise that factors affecting muscular blood flow and nutrient delivery to the muscle are those of most importance in inducing insulin resistance. Increased sympathetic drive induces small vessel rarefication or loss of capillary density causes vasoconstriction (via a-receptor) and facilitate the shunting of glucose and insulin to less metabolically active skletal muscle beds. The metabolic properties of antihypertensive agents give further credence to the hemodynamic model of insulin resistance. Vasoconstriction mediated by b-blockers and vasodilatation by a-blockers parallel by their metabolic properties. Thus b-blockers that do vasoconstrict induce insulin resistance, but those with a-blocking properties are not causing insulin resistance.
Subjects
Obesity & Weight ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Obesity & Weight Loss Therapy.
Research article · 27 Feb 2026
Modulation of Postprandial GLP-1 Secretion and Glycemic Responses by a Food-Grade GLP-1 Formula in Human Subjects
Short communication · 9 Feb 2026
Intensive Blood Pressure Lowering Target Guided by Home Blood Pressure Monitoring for Hypertensive Patients with Type 2 Diabetes, Which is Better or Not
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Obesity & Weight Loss Therapy
- SubjectObesity & Weight Management
- BylineArticles whose byline prints “Risto Kaaja”
